Adherence Improvement Research Starter Grant

Funding Agency:
Pharmaceutical Research and Manufacturers of America Foundation

A growing body of evidence demonstrates that good adherence to recommended medications can yield better clinical outcomes and reduce downstream medical spending for patients with chronic conditions. However, many people do not take their medications as prescribed. Closing the adherence gap is important for improving the quality of health care, encouraging better chronic care management, and promoting better outcomes.

Our goal is to support research that will advance knowledge of innovative and effective approaches to improve medication adherence. Relevant research goals may include development or evaluation of policies, interventions, or tools that have potential to improve medication adherence.

The proposed research may target one or multiple therapeutic class(es) of medication(s) or condition(s), but not individual products. A focus on priority conditions affecting Medicare and Medicaid is encouraged, e.g. diabetes, cardiovascular disease, chronic obstructive pulmonary disease/asthma, heart failure, hypertension, dementia, and cancer. Real-world applicability of the intervention and generalizability of the findings to broader populations and settings should be considered.

Deadline: Sep. 1, 2016

Agency Website

Eligibility Requirements

Individuals holding the academic rank of instructor, assistant professor, or investigator at the doctoral level by January 2017 are eligible to apply for a research starter grant.
The proposed research should focus on adherence improvement.
The program is not intended for individuals in postdoctoral training programs.
Applicants must be sponsored by the department within which the proposed research is to be undertaken. Schools of medicine, pharmacy, public health, nursing, and schools of other areas where appropriate are eligible for this award.
The PhRMA Foundation project officer must be informed if other support is obtained after the application has been submitted.
Applicants must reside in the U.S. with a firm commitment from an accredited U.S. university. There is no citizenship requirement.



Amount Description

The grant provides funding of $50,000 for one year.
The grant is paid on a quarterly basis to the university on behalf of the applicant, with the understanding that the university will administer the funds.
The funds have limited restrictions – a characteristic of the program.
The funds may be used for salary support but should not exceed 25%.
The support of technical assistance may include the hourly wages of a technician; however the funds may not be used to provide fringe benefits or indirect costs for the technician.
$1,500 per year may be used for travel to professional meetings by the grantee.
PhRMA Foundation funds may not be used for indirect costs or fringe benefits.
These funds are not transferable.

Funding Type



Junior Faculty


Environmental & Life Sciences
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

September 1, 2016